Auguste D.
- Country
- France
- Department
- réanimation
Research Overview
- Human recombinant interferon gamma in the treatment of ventilator-acquired pneumonia in ICU patients. IGNORANT study
- Efficacy of Dexmedetomidine as Adjunctive Therapy for Refractory Septic Shock in Mechanically Ventilated Patients: A Randomized Controlled Trial
- Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Regimen in Critical Care Patients with Sepsis
Data & Insights
Has run more than one trial at 14 of 49 partner sites.
Specializations
Critical Care Medicine
The investigator specializes in treating patients with ventilator-acquired pneumonia (VAP) in intensive care settings, with particular focus on developing innovative therapeutic approaches for mechanically ventilated patients.
- Respiratory Infections in ICU
- Mechanical Ventilation Management
- Critical Care Therapeutics
Their research explores the application of immunomodulatory therapies in critical care settings.
Immunotherapy Research
The investigator focuses on studying recombinant human interferon gamma and its therapeutic applications in critical illness, particularly examining immune response modulation in severe infections.
- Immune System Modulation
- Biological Response Modifiers
- Infection Control Strategies
Their work includes evaluation of immune markers such as mHLA-DR in critical care patients.
Infectious Disease Management
The investigator concentrates on developing treatment strategies for hospital-acquired infections, specifically in mechanically ventilated patients in intensive care units.
- Antibiotic Treatment Optimization
- Hospital-Acquired Pneumonia
- Infection Prevention Protocols
Their research encompasses combined therapeutic approaches using both antimicrobial agents and immunomodulators.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.